Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

CompanDX Ltd. and Clinical Reference Laboratory, Inc. Sign Multi-Year Deal in Support of Collaborative Gene Signature and Companion Diagnostic Development

February 19, 2011 3:31 am | News | Comments

LENEXA, Kan., Feb. 19, 2011 /- CompanDX Ltd., bioinformatics partner for the life sciences industry, and Clinical Reference Laboratory, Inc. (CRL), provider of laboratory testing services in molecular diagnostics and clinical trials, today announced they entered into a multi-year...

TOPICS:

Hamstring grafts prove more effective in ACL knee reconstruction, study says

February 18, 2011 8:40 pm | News | Comments

(American Orthopaedic Society for Sports Medicine) Patients receiving anterior cruciate ligament knee reconstruction with a hamstring tendon graft rather than a knee tendon graft were less likely to suffer from pain and mobility issues15 years after surgery, say researchers...

TOPICS:

FDA Down-Classifies MDDS to Class I Via Final Rule

February 18, 2011 7:30 pm | News | Comments

The FDA has down-classified medical device data systems (MDDS) from Class III into Class I via a final rule, which could help manufacturers compete with IT companies in this area.

TOPICS:
Advertisement

FDA Questions UK Regulator & #8217;s Data on Hip Implant Recalls(2)

February 18, 2011 5:31 pm | News | Comments

Quality problems with metal-on-metal (MoM) hip replacement systems, like Johnson & Johnson (J&J)’s ASR devices, may not be as widespread as UK data indicates, the FDA says.

TOPICS:

FDA Questions UK Regulator & #8217;s Data on Hip Implant Recalls

February 18, 2011 5:30 pm | News | Comments

Quality problems with metal-on-metal (MoM) hip replacement systems, like Johnson & Johnson (J&J)’s ASR devices, may not be as widespread as UK data indicates, the FDA says.

FDA Panel to Weigh in on Future of DTC Genetic Tests

February 18, 2011 1:35 pm | News | Comments

Makers of direct-to-consumer (DTC) genetic tests are a step closer to learning how the FDA will regulate those products.

Study explores ability of professional dancers to return to their career after hip arthroscopy

February 18, 2011 12:31 pm | News | Comments

(Hospital for Special Surgery) A new study has identified factors that predict the ability of a professional dancer to return to performance after hip arthroscopy surgery. The results of this Hospital for Special Surgery study indicated that ballet dancers were significantly less...

TOPICS:

EPS up 27% for the Quarter and 19% for the Year Over Adjusted EPS for Prior Periods

February 18, 2011 11:45 am | News | Comments

Atrion Corporation (NASDAQ: ATRI) announced today that revenues and earnings were higher for the fourth quarter and the full year 2010 compared to the quarter and year ended December 31, 2009. Revenues for the fourth quarter of 2010 were $26.6 million compared to $24.4 million in the...

Advertisement

Insurer Amerigroup says 4Q profit nearly doubles

February 18, 2011 10:45 am | News | Comments

Heath insurer Amerigroup Corp. said Friday its fourth-quarter net income nearly doubled from a year ago on rate increases in three states.The results beat Wall Street's expectations and shares climbed $2.29, or 4.1 percent, to $58.09 in afternoon trading.Net income rose to $79.6 million, or...

Saint Louis U Scientists Partner on Malaria Research

February 18, 2011 10:34 am | News | Comments

ST. LOUIS, Feb. 18, 2011 /PRNewswire-USNewswire/ --  The Center for World Health & Medicine at Saint Louis University and China's Guangzhou Institutes of Biomedicine and Health (GIBH) are forming a global research partnership that initially will focus on new treatments for...

TOPICS:

Grifols Starts Construction of a New Plasma Fractionation Plant in Barcelona (Parets Del Valles)

February 18, 2011 10:34 am | News | Comments

BARCELONA, Spain, Feb. 18, 2011 /- Grifols, the Spanish group which specializes in the hospital-pharmaceutical sector and is one of the world's leading producers of plasma products, will shortly start construction of a new plant representing an investment of 20 million euros that will...

TOPICS:

Smith & Nephew's Exclusive OXINIUMâ„¢ Material for Hip Replacement Implants Chosen for Premium Reimbursement in Japanese Market

February 18, 2011 10:34 am | News | Comments

MEMPHIS, Tenn., Feb. 18, 2011 /- OXINIUM™ Oxidized Zirconium, the patented advanced bearing material from Smith & Nephew (NYSE: SNN, LSE: SN) Orthopaedics Division, has been awarded a C1 premium reimbursement classification in Japan for use in hip replacement surgery. The...

TOPICS:

Creature Feature: Jumping Fleas, Burrowing Owls

February 18, 2011 9:39 am | Podcasts | Comments

Science Friday's video pick is a double feature. Scientists in the U.K. used high-speed photography to reveal how fleas leap. Mac Stone, wildlife photographer and field biologist, stuffed a camera in a traffic cone and got some beauty shots of burrowing owls in south Florida.

Can Science Be Used As A Diplomatic Tool?

February 18, 2011 9:39 am | Podcasts | Comments

Some moon craft house instruments from a handful of countries — an example of international scientific collaboration. But how valuable is science in the diplomatic sphere? Biologist Nina Fedoroff, former science adviser to both Condoleezza Rice and Hillary Clinton, talks about her time in...

Rumbling Underground, An Engineering Feat

February 18, 2011 9:39 am | Podcasts | Comments

In 2009, 1.6 billion people hopped on the New York City subway. But how was it built? MTA Capital Construction president Michael Horodniceanu and historian Clifton Hood discuss the engineering techniques used to tunnel through Manhattan — from sticks of dynamite to a one-million-pound...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading